Michael Francis Graybar Jr., DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 116 N Norwood St, Wallace, NC 28466 Phone: 910-285-7222 Fax: 910-285-7229 |
Graybar Chiropractic, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 116 N Norwood St, Wallace, NC 28466 Phone: 910-285-7222 Fax: 910-285-7229 |
Maryann E. Luxeder, DC OF CHIROPRACTIC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 116 N Norwood St, Wallace, NC 28466 Phone: 910-285-7222 Fax: 910-285-7229 |
Kelly Chiropractic Center Of Wallace Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 112 Medical Village Dr, Suite A, Wallace, NC 28466 Phone: 910-285-9002 |
Dr. Glenn James Lundy, D.C. Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 116 N Norwood St, Wallace, NC 28466 Phone: 910-285-7222 Fax: 910-285-7229 |
News Archive
Assisted reproductive technology may be associated with the increased proportion of multiple birth infants affected by congenital abnormalities since the 1980s, European research suggests.
Imprimis Pharmaceuticals, Inc., a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding business model, today announced the availability of its new MaxRx Prescriber Portal, a software application that provides physicians with new order entry and management tools that have traditionally not been available for compounded prescriptions.
CHILDREN with a rare type of cancer called Wilms' tumour who are at low risk of relapsing can now be given less intensive treatment, avoiding a type of chemotherapy that can cause irreversible heart problems in later life.
Merge Healthcare, a leading health IT solutions provider, successfully deployed an imaging distribution solution for the physicians of UMass Memorial Health Care, an academic medical center with five facilities serving Central New England. iConnect Access™ gives physicians the ability to view medical images directly from their electronic health record.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential. Palatin's lead product under development is bremelanotide for the treatment of female sexual dysfunction (FSD).
› Verified 2 days ago